Ya’nan Ren

Preclinical evaluation and first in human study of Al18F radiolabeled ODAP-urea-based PSMA targeting ligand for PET imaging of prostate cancer

Jiayue Liu, Xing Yang, Hua Zhu, 2022, Frontiers in Oncology.

68Ga-labeled ODAP-Urea-based PSMA agents in prostate cancer: first-in-human imaging of an optimized agent

M. Pomper, Jinming Zhang, Xiaojun Zhang, 2021, European Journal of Nuclear Medicine and Molecular Imaging.

Evaluation of 68Ga- and 177Lu-Labeled HZ20 Angiotensin-Converting Enzyme 2-Targeting Peptides for Tumor-Specific Imaging.

Hua Zhu, Zhi Yang, Nina Zhou, 2022, Molecular pharmaceutics.